ASLAN Pharmaceuticals Competitors and Similar CompaniesClear all
ASLAN Pharmaceuticals's competitors and similar companies include Telix Pharmaceuticals, NiKang Therapeutics, Oricell Therapeutics and Leap Therapeutics.
 ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. |  Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. |  NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. |  Oricell Therapeutics OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development. |  Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. | |
Founding Date | Founding Date N/A | Founding Date 2015 | Founding Date 2017 | Founding Date 2015 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations SG HQ Collingwood, AU | Locations Wilmington, US HQ | Locations Shanghai, CN HQ | Locations Cambridge, US HQ | |
Employees | Employees 35 | Employees 415 | Employees 403% increase | Employees 235% increase | Employees 688% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.6 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 176.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $803.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $356m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $12m (FY, 2023) | Gross profit $449m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($44.2m) (FY, 2023) | Net income ($7.1m) (FY, 2025) | Net income N/A | Net income N/A | Net income $4.8m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 23m (almost 10 years ago) | Latest funding round N/A | Latest funding round $ 200m (almost 5 years ago) | Latest funding round $ 120m (almost 4 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 100m | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 162m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Telix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
View companyNiKang Therapeutics
HQ
Wilmington, US
Employees
40↑ 3% increase
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View companyOricell Therapeutics
HQ
Shanghai, CN
Employees
23↑ 5% increase
OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development.
View companyLeap Therapeutics
HQ
Cambridge, US
Employees
6
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View company